What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 19.3% in the morning session after it ...
Genetic testing company Myriad Genetics (NASDAQ:MYGN) in Q3 CY2025, but sales fell by 3.6% year on year to $205.7 million.
Sophia Genetics has launched an artificial-intelligence-powered tool that creates virtual copies of patients, known as digital twins, that could one day be used to help doctors test the potential of ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its third ...
Founded in 2021, T3 Molecular Genetics Pvt Ltd. (T-3MGen) operates in the Health Tech sector offering new therapeutic interventions through multi-disciplinary ...
The agri-biotech is developing a bovine IVF platform  to deliver scalable, high-quality outcomes for cattle producers ...
Researchers have developed an improved method of gene editing that is precise, more efficient than other similar methods and ...